Yale Medicine School: Use of Anticoagulants Within 24 Hours of Hospitalization Can Reduce Death in COVID-19 Patients
February 16, 2021
February 16, 2021
NEW HAVEN, Connecticut, Feb. 16 (TNSJou) -- Yale School of Medicine issued the following news:
Blood clots, through venous thromboembolism and arterial thromboses, have been shown to be one of the causes of death in individuals with COVID-19. Medications that prevent blood clots, or anticoagulants, may be effective in treating patients with the disease. New research published in The BMJ shows that patients put on preventative doses of anticoagulants within the first 24 hours of bein . . .
Blood clots, through venous thromboembolism and arterial thromboses, have been shown to be one of the causes of death in individuals with COVID-19. Medications that prevent blood clots, or anticoagulants, may be effective in treating patients with the disease. New research published in The BMJ shows that patients put on preventative doses of anticoagulants within the first 24 hours of bein . . .